1. Home
  2. CADL vs CCO Comparison

CADL vs CCO Comparison

Compare CADL & CCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$11.74

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.39

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
CCO
Founded
1999
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
CADL
CCO
Price
$11.74
$2.39
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$19.00
$2.12
AVG Volume (30 Days)
1.1M
4.8M
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
110.81
EPS
N/A
N/A
Revenue
$125,000.00
$1,604,140,000.00
Revenue This Year
N/A
$5.35
Revenue Next Year
N/A
$4.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.57
52 Week Low
$4.35
$1.27
52 Week High
$14.00
$2.44

Technical Indicators

Market Signals
Indicator
CADL
CCO
Relative Strength Index (RSI) 48.82 53.28
Support Level $9.40 $2.37
Resistance Level $14.00 $2.41
Average True Range (ATR) 0.71 0.02
MACD -0.18 0.00
Stochastic Oscillator 46.56 80.00

Price Performance

Historical Comparison
CADL
CCO

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

Share on Social Networks: